The most frequent HLA class II allele in the MS patient group was HLA-DRB1*15:01 (11 out of the 22 MS patients), which was found in just one control patient (Fisher’s exact test, p = 0.0994, odds ratio = 6.61). This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.